FR2310133A2 - Nouveau medicament comportant un activateur du plasminogene perfectionne - Google Patents

Nouveau medicament comportant un activateur du plasminogene perfectionne

Info

Publication number
FR2310133A2
FR2310133A2 FR7513932A FR7513932A FR2310133A2 FR 2310133 A2 FR2310133 A2 FR 2310133A2 FR 7513932 A FR7513932 A FR 7513932A FR 7513932 A FR7513932 A FR 7513932A FR 2310133 A2 FR2310133 A2 FR 2310133A2
Authority
FR
France
Prior art keywords
improved
product containing
plasminogen activator
medicinal product
new medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7513932A
Other languages
English (en)
Other versions
FR2310133B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7513932A priority Critical patent/FR2310133A2/fr
Priority to BE166547A priority patent/BE841251R/fr
Priority to US05/682,283 priority patent/US4083961A/en
Priority to DE2619667A priority patent/DE2619667C2/de
Priority to ES447803A priority patent/ES447803A2/es
Priority to GB18369/76A priority patent/GB1551275A/en
Publication of FR2310133A2 publication Critical patent/FR2310133A2/fr
Application granted granted Critical
Publication of FR2310133B2 publication Critical patent/FR2310133B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7513932A 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne Granted FR2310133A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7513932A FR2310133A2 (fr) 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne
BE166547A BE841251R (fr) 1975-05-05 1976-04-28 Procede d'obtention d'un activateur du plasminogene
US05/682,283 US4083961A (en) 1975-05-05 1976-05-03 Plasminogen activator pharmaceutical compositions
DE2619667A DE2619667C2 (de) 1975-05-05 1976-05-04 Pharmazeutisches Mittel
ES447803A ES447803A2 (es) 1975-05-05 1976-05-05 Procedimiento de obtencion de un activador del plasminogeno.
GB18369/76A GB1551275A (en) 1975-05-05 1976-05-05 Process for the preparation of plasminogen activators and pharmaceutical compositions containing plasminogen activators obtained by the process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7513932A FR2310133A2 (fr) 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne

Publications (2)

Publication Number Publication Date
FR2310133A2 true FR2310133A2 (fr) 1976-12-03
FR2310133B2 FR2310133B2 (fr) 1978-12-01

Family

ID=9154824

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7513932A Granted FR2310133A2 (fr) 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne

Country Status (6)

Country Link
US (1) US4083961A (fr)
BE (1) BE841251R (fr)
DE (1) DE2619667C2 (fr)
ES (1) ES447803A2 (fr)
FR (1) FR2310133A2 (fr)
GB (1) GB1551275A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0023860A2 (fr) * 1979-07-27 1981-02-11 Pierre Fabre S.A. Procédé perfectionné de préparation d'activateur du plasminogène, activateur ainsi obtenu et médicament le contenant
FR2462165A2 (fr) * 1973-12-03 1981-02-13 Fabre Sa Pierre Procede perfectionne de preparation d'activateur du plasminogene
EP0041449A1 (fr) * 1980-05-29 1981-12-09 Pierre Fabre S.A. Application d'une composition ophtalmique contenant un activateur du plasminogène, au nettoyage des lentilles cornéennes
EP0198321A1 (fr) * 1985-04-11 1986-10-22 BEHRINGWERKE Aktiengesellschaft Médicament contenant un activateur de plasminogène

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2121050B (en) * 1979-07-05 1986-03-26 Genentech Inc Preparation of functional human urokinase proteins
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
US5112755A (en) * 1982-04-15 1992-05-12 Genentech, Inc. Preparation of functional human urokinase proteins
US4853330A (en) * 1983-04-07 1989-08-01 Genentech, Inc. Human tissue plasminogen activator
SU1662352A3 (ru) * 1982-05-05 1991-07-07 Генентек, Инк (Фирма) Штамм бактерий ЕSснеRIснIа coLI - продуцент активатора плазминогена тканевого типа
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
FI831484L (fi) 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
US5120715A (en) * 1988-12-12 1992-06-09 Takeda Chemical Industries, Ltd. Method for purifying fibroblast growth factor protein
US6207151B1 (en) * 1989-09-21 2001-03-27 Mitsui Chemicals Inc. Aqueous solution of t-PA
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
US5288489A (en) * 1991-08-28 1994-02-22 Orion Therapeutic Systems, Inc. Fibrinolysis and fibrinogenolysis treatment
US6261820B1 (en) * 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
AU2006200638B2 (en) * 1999-10-01 2007-11-01 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
AU2004201694B2 (en) * 1999-10-01 2006-03-02 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6440414B1 (en) * 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US7033776B2 (en) * 1999-12-17 2006-04-25 Amgen Inc. Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2153200A1 (en) * 1971-09-24 1973-05-04 Choay Sa Stable,pyrogen-free urokinase prepns - from human urine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2153200A1 (en) * 1971-09-24 1973-05-04 Choay Sa Stable,pyrogen-free urokinase prepns - from human urine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOCHEMISTRY, VOL. 3, 1578-1585 1964 ) *
CHEMICAL ABSTRACTS VOL. 81, 36027A 1974 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462165A2 (fr) * 1973-12-03 1981-02-13 Fabre Sa Pierre Procede perfectionne de preparation d'activateur du plasminogene
EP0023860A2 (fr) * 1979-07-27 1981-02-11 Pierre Fabre S.A. Procédé perfectionné de préparation d'activateur du plasminogène, activateur ainsi obtenu et médicament le contenant
EP0023860A3 (en) * 1979-07-27 1981-02-18 Pierre Fabre S.A. Improved method for preparing plasminogen activator, activator thus obtained and medicine comprising it
EP0041449A1 (fr) * 1980-05-29 1981-12-09 Pierre Fabre S.A. Application d'une composition ophtalmique contenant un activateur du plasminogène, au nettoyage des lentilles cornéennes
EP0198321A1 (fr) * 1985-04-11 1986-10-22 BEHRINGWERKE Aktiengesellschaft Médicament contenant un activateur de plasminogène

Also Published As

Publication number Publication date
FR2310133B2 (fr) 1978-12-01
BE841251R (fr) 1976-10-28
GB1551275A (en) 1979-08-30
ES447803A2 (es) 1977-07-01
DE2619667A1 (de) 1976-11-18
US4083961A (en) 1978-04-11
DE2619667C2 (de) 1984-12-06

Similar Documents

Publication Publication Date Title
FR2310133A2 (fr) Nouveau medicament comportant un activateur du plasminogene perfectionne
PH17318A (en) Manufacture of pharmaceutical unit dosage forms
SE428426B (sv) Anordning for inandning av lekemedel i pulverform
PH14489A (en) Manufacture of pharmaceutical dosage form
BE833762A (fr) Supports pour medicaments
SE411517B (sv) Inhalator for administration av pulverformiga substanser
EG11922A (en) Medicament infusor unit
SE416519B (sv) Tvakammarspruta
GB1551055A (en) Capsule syringes
GB2126517B (en) Method of manufacture of hypodermic syringe
SE7512274L (sv) Farmaceutisk komposition for topisk behandling av skinn
SE7607154L (sv) Anordning for administrering av bedovningsmedel
FR2312240A1 (fr) Derives du prostane et medicaments qui en contiennent
DK90376A (da) Medicinpakning
JPS5251367A (en) Production of novel substituted 44aminopyrazole and pharmaceutical agent containing the same
IL47877A (en) Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
LU77557A1 (fr) Nouveau 2-deoxystreptamine-aminoglycoside,son procede de preparation et medicament le contenant
FR2307538A1 (fr) Nouveau medicament anti-agregant plaquettaire
BE835915A (fr) Nouveau medicament du type numapeptide
IL46682A (en) Pharmaceutical capsules containing difoxin
JPS5273885A (en) Benzopyron derivative and its production and drugs having antiiallergy effect containing same
FR2307526A1 (fr) Oxo-11 prostaglandines et medicaments qui en contiennent
FR2314724A1 (fr) Medicament anticonvulsif contenant un diphenylsilane
IE41277L (en) Determination of human plasminogen
BE842043R (fr) Dilatateur nouveau